A systematic approach to the treatment of skin diseases significantly reduces the treatment time of the disease and improves the patient's quality of life. Following the commandment to treat the patient and not the disease, systemic drugs in the complex therapy of dermatoses play an important role. Based on the diagnosis, the results of the clinical examination and laboratory tests, the treatment tactics are determined by the clinic's expert in accordance with the existing protocols. Therapy and its duration are prescribed individually, taking into account the age and gender of the patient, history data, stage and severity of the disease, and the prevalence of rashes. Individual intolerance to drugs must be taken into account.
Systemic therapy includes the administration of injections (intravenous, intramuscular, intradermal) and tablets. Systemic therapy is usually used for moderate to severe or severe disease, and it has its own characteristics, it can be etiotropic and pathogenetic action: specific to the pathogen, immunosuppressive, anti-inflammatory, desensitizing, eliminating pathologies of internal organs, antiallergic, symptomatic therapy, eliminating foci of chronic infection, stabilizing the nervous system, normalizing the work of the endocrine glands.
Systemic therapy is prescribed when a patient is diagnosed with such dermatoses as: pemphigus, lupus erythematosus, erythroderma, dermatomyositis, generalized psoriasis and psoriatic arthritis, allergic dermatosis, including atopic dermatitis, acne, rosacea, pyoderma, dermatomycosis, tuberculosis, scabies etc.